2019
DOI: 10.4103/ijpm.ijpm_543_18
|View full text |Cite
|
Sign up to set email alerts
|

Immunophenotyping of male breast cancer - Experience at a tertiary care centre

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(6 citation statements)
references
References 2 publications
0
6
0
Order By: Relevance
“…Axillary involvement is present in approximately 30-50% of the cases at the time of diagnosis ( 2 , 14 ) and was present in 9/27 (33%) of our cases. Most male breast cancers are usually positive for ER (65-97%) and PR (60-85%) ( 2 , 4 , 13 , 14 , 22 , 23 ). The Her2/neu positivity rate is 3-28% ( 14 , 22 , 24 ).…”
Section: Discussionmentioning
confidence: 59%
See 4 more Smart Citations
“…Axillary involvement is present in approximately 30-50% of the cases at the time of diagnosis ( 2 , 14 ) and was present in 9/27 (33%) of our cases. Most male breast cancers are usually positive for ER (65-97%) and PR (60-85%) ( 2 , 4 , 13 , 14 , 22 , 23 ). The Her2/neu positivity rate is 3-28% ( 14 , 22 , 24 ).…”
Section: Discussionmentioning
confidence: 59%
“…Among male breast cancers, IC-NST (80-90%) is the most common histopathological diagnosis followed by papillary carcinomas. Less often, ILC, mucinous carcinoma and apocrine carcinoma are detected ( 8 , 14 ). In our series, 23 IC-NST, two ILC, one IMPC with apocrine features, and one mixed carcinoma (IC-NST with cribriform carcinoma) were observed, consistent with the literature.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations